Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer

e-ESO Podcasts
16/05/2024 5 min Temporada 4 Episodio 10

Listen "Molecular Classification Predicts Response to Radiotherapy in the Randomized PORTEC-1 and PORTEC-2 Trials for Early-Stage Endometrioid Endometrial Cancer"

Descargar episodio Ver en sitio original

Episode Synopsis

Expert: Radwa Hamed Sabra, Lecturer of Clinical Oncology, Armed Forces College of Medicine Egypt, Cairo, Egypt

More episodes of the podcast e-ESO Podcasts

Angiosarcoma Essentials 18/12/2024
The Lines of Therapy After Progression on CDK4/6 Inhibitors Plus Endocrine Therapy to Overcome the Resistance in HR+/Her2 - Metastatic Breast Cancer Patients 12/12/2024
Women’s Health Frontiers: Breakthroughs from ESMO 2024 28/11/2024
ESMO Congress Prostate Cancer Highlights 14/11/2024
How to interpret prognostic models papers in hematology and oncology 31/10/2024
Stage III Lung Cancer Resecability 17/10/2024
Exercise, Diet, and Weight Management During Cancer Treatment: ASCO Guideline 03/10/2024
Clinical approach and therapeutic overview on gastroenteropancreatic neoendocrine tumours (GEP-NENS) 19/09/2024
Fear of recurrence: one of the major elements in reactivating cancer 25/07/2024
Immunohistochemistry in oncology 11/07/2024
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA